European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.
about
Neoplastic disease after liver transplantation: Focus on de novo neoplasmsBody mass index and outcome in renal transplant recipients: a systematic review and meta-analysisRenal and cardiac assessment of living kidney donor candidates.Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.Revascularisation of patients with end-stage renal disease on chronic haemodialysis: bypass surgery versus PCI-analysis of routine statutory health insurance data.Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation.Management and prevention of post-transplant malignancies in kidney transplant recipientsOlder candidates for kidney transplantation: Who to refer and what to expect?A Clinical Prediction Score to Guide Referral of Elderly Dialysis Patients for Kidney Transplant Evaluation.KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group.Comparison of trends in colorectal cancer screening in the US end-stage renal disease population and the US Medicare population.Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.Estimated or Measured GFR in Living Kidney Donors Work-up?Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports.Prevalence and survival prognosis of prostate cancer in patients with end-stage renal disease: a retrospective study based on the Korea national database (2003-2010).Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?What is the significance of end-stage renal disease risk estimation in living kidney donors?The impact of human leukocyte antigen mismatching on graft survival and mortality in adult renal transplantation: A protocol for a systematic review and meta-analysis.Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy.Development of a Donor-Centered Approach to Risk Assessment: Rebalancing Nonmaleficence and Autonomy.Influence of specific thoracic donor therapy on kidney donation and long-term kidney graft survival.Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board.Unacceptable human leucocyte antigens: how to navigate between increased immunological risk and waiting time?Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy.Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial.Survival in Southern European patients waitlisted for kidney transplant after graft failure: A competing risk analysis.What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients.Renal biopsy: it is time for pragmatism and consensusChronic kidney disease
P2860
Q26798306-6FE4CDF3-FCFF-4B4C-8B37-234F476B8858Q28085010-B06C59AA-1A42-45EE-A8FC-3F3A867847D8Q30234993-90EE5ADA-4F22-41FB-8518-35A5618CF622Q31119121-98022BC3-C351-4984-9298-09ABCBD2F5A0Q31137328-C7EEB482-2CB2-4BFD-B4CA-2B8A3A20002EQ35568602-11764BA5-99DC-48F8-9A77-F4DB75C57B79Q36088854-85EAF6AC-6AF9-4108-8DE7-E29C1DE9922CQ37522567-1F7633B7-03A9-4F86-94AE-ABB96A08A8C3Q38606158-2E036BFE-6B63-45F8-91BE-D0CC7F07D9DDQ38652031-9C33D292-AFA2-4524-B990-C1715E88A113Q39130132-BB88BE23-A9FA-43F6-801F-4A9DA38D8C3EQ39344475-D806A3A8-72D9-499A-AE45-A39EC1CBAC4AQ40151738-888BE7CC-0496-4545-8622-64D672CC49F1Q40713226-25BA6FC5-711E-4041-8DA2-B8484E953CE7Q41217389-97E02DD8-0FD2-4BA3-9C86-C12245F95289Q42362786-1908E8A9-3D72-4428-8A23-9ADFD466C7EDQ42371674-13EF392B-8591-4FA6-9193-773C78A78721Q47335194-E5FBB9AB-7F1C-4C2C-99EB-D6A8F1A5C13FQ47393881-F4260CEE-1A50-44C9-9E60-534160AFA1F9Q47702883-33AB149B-B72B-41E7-8564-D48C485E1C62Q48041047-7F797BDC-4264-4546-B22C-082E2850346DQ48434945-F9EF8BD4-966F-4351-8C6F-7A5B3E3446CDQ50000836-5E96DDE2-4CD2-476F-9AB3-4DCD6D0007FFQ50753647-B8464D2F-A47C-4CF2-8DB2-F11EC4C396D7Q52852198-CC980FB0-0C12-47C6-A2F9-37F2800F09FAQ54211998-8EDCEE79-4B1B-4A23-A03C-97E12E99F60DQ54260693-E9F31740-9F08-4D4A-8E11-4E4CFB569A45Q55080670-9D040A62-167C-4B17-8C94-7E8FBC172871Q57053820-AFF2AB5B-5739-451F-A7BD-D21C62AFDCC3Q57701181-112F15C8-8477-43EC-B3DF-E2799ABD0887
P2860
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
European Renal Best Practice G ...... uation and perioperative care.
@en
type
label
European Renal Best Practice G ...... uation and perioperative care.
@en
prefLabel
European Renal Best Practice G ...... uation and perioperative care.
@en
P2093
P50
P356
P1476
European Renal Best Practice G ...... uation and perioperative care.
@en
P2093
Armando Torres
Daniel Abramowicz
Evi Nagler
Frans H J Claas
Jean-Paul Squifflet
Julio Pascual
Jürg Steiger
Marivonne Hourmant
Martin Zeier
P304
P356
10.1093/NDT/GFU216
P407
P577
2014-07-09T00:00:00Z